Pharmaceutical formulation
    6.
    发明授权
    Pharmaceutical formulation 失效
    药物制剂

    公开(公告)号:US07842308B2

    公开(公告)日:2010-11-30

    申请号:US10470439

    申请日:2002-01-30

    IPC分类号: A61K9/48

    CPC分类号: A61K9/4816 A61K9/4808

    摘要: The present invention is directed to pharmaceutically acceptable polymeric compositions suitable for injection molding of single or multi-component pharmaceutical dosage forms comprising a plurality of drug substance containing sub-units, being capsule compartments and/or solid sub-units comprising a solid matrix of a polymer which contains a drug substance, the sub-units being connected together in the assembled dosage form by a weld between parts of the assembled dosage form.

    摘要翻译: 本发明涉及适于注射模塑单组分或多组分药物剂型的药学上可接受的聚合物组合物,其包含多个含药物物质的子单元,包括胶囊隔室和/或包含固体基质的固体亚单元 含有药物的聚合物,所述子单元通过组装的剂型的部分之间的焊接在组装的剂型中连接在一起。

    Pharmaceutical formulations
    7.
    发明授权
    Pharmaceutical formulations 失效
    药物制剂

    公开(公告)号:US08673350B2

    公开(公告)日:2014-03-18

    申请号:US10565462

    申请日:2004-07-21

    摘要: The present invention is directed to novel pharmaceutically acceptable polymeric compositions suitable for injection molding of single or multi-component pharmaceutical dosage forms comprising a plurality of drug substance containing sub-units, being capsule compartments and/or solid sub-units comprising a solid matrix of a polymer which contains a drug substance, the sub-units being connected together in the assembled dosage form by a weld between parts of the assembled dosage form.

    摘要翻译: 本发明涉及适用于注射模塑单组分或多组分药物剂型的新型药学上可接受的聚合物组合物,其包含多个含药物物质的子单元,其为胶囊隔室和/或固体亚单位,其包含固体基质 含有药物的聚合物,所述子单元通过组装的剂型的各部分之间的焊接在组装的剂型中连接在一起。